Regeneron Pharmaceuticals Inc vs Super Micro Computer Inc — how do they compare? Regeneron Pharmaceuticals Inc trades at $653.5 (market cap $70.79B), while Super Micro Computer Inc trades at $31.19 (market cap $16.50B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 4.3× Super Micro Computer Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Super Micro Computer Inc pays none. Which is the better fit depends on your goals.
| REGN | SMCI | |
|---|---|---|
Market Cap | $70.79B | $16.50B |
Sector | Health | Technology |
52-Week High | $812.27 | $60.71 |
52-Week Low | $545.46 | $20.53 |
Enterprise Value | $64.74B | $24.01B |
Dividend Yield | 0.56% | — |
Trailing returns across standard periods
Latest headlines on both assets
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →